John E Macor

USPTO Granted Patents = 118 (Patent Applications = 43)

CIPO Patents = 7 (Patent Applications = 16)

EPO Patents = 52 (Patent Applications = 61)

Average Co-Inventor Count = 5.5

ph-index = 13

Forward Citations = 694(Granted Patents)

Forward Citations (Not Self Cited) = 632(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Penfield, NY (US) (1999 - 2000)
Princeton, NJ (US) (2004)
Gilford, CT (US) (2008)
Flemington, NJ (US) (2000 - 2009)
Guildord, CT (US) (2012)
Gullford, CT (US) (2012 - 2013)
Guilford, CT (US) (2003 - 2019)
Washington Crossing, PA (US) (2015 - 2024)

Company Filing History:

111 out of 3,684

Bristol-myers Squibb Compnay

Lexicon Pharmaceuticals, Inc.

Syngene International Limited

Bristol Meyers Squibb Company

patents

8. 1 out of 97

Albany Molecular Research, Inc.

patents

where one patent can have more than one assignee

Years Active: 1999-2024

Loading Chart...

Areas of Expertise:

Kinase Inhibitors

Gsk-3 Inhibitors

Selective NR2B Antagonists

Indole Compounds

Aminopyrrolotriazines

Biaryl Compounds

Triazolo Compounds

Pyridine Derivatives

Heterocyclic Compounds

Oxazolidinones

Neurological Disorders

Receptor-Interacting Protein Kinase 1

118 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12172975 - 1H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RIPK1) (2024-12-24),

2. 12157733 - Aminotriazolopyridines as kinase inhibitors (2024-12-03),

3. 12084426 - Indazole carboxamides as kinase inhibitors (2024-09-10),

4. 12065437 - Biaryl kinase inhibitors (2024-08-20),

5. RE49893 - [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds (2024-04-02),

6. RE49880 - [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds (2024-03-26),

7. 11739098 - Substituted indole compounds (2023-08-29),

8. 11672780 - [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds (2023-06-13),

9. 11623921 - Indole carboxamide compounds (2023-04-11),

10. 11618753 - Aminopyrrolotriazines as kinase inhibitors (2023-04-04),

11. 11440913 - Aminoimidazopyridazines as kinase inhibitors (2022-09-13),

12. 11180474 - Dimethoxyphenyl substituted indole compounds as TLR7, TLR8 or TLR9 inhibitors (2021-11-23),

13. 11053258 - Pyrimidine carboxamides as GSK-3 inhibitors (2021-07-06),

14. 11053197 - Carbazole derivatives (2021-07-06),

15. 10981910 - Biaryl kinase inhibitors (2021-04-20),

Title: John E Macor - Innovator from Guilford, CT

Introduction: John E Macor is a renowned inventor hailing from Guilford, CT, known for his groundbreaking contributions to various industries.

Latest Patents: John E Macor holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovative ideas.

Career Highlights: Throughout his career, John E Macor has been recognized for his ability to transform creative concepts into tangible inventions that have had a significant impact on society. His dedication to pushing the boundaries of innovation has led to numerous successful ventures.

Collaborations: John E Macor has collaborated with leading companies, research institutions, and universities to further develop his inventions and bring them to the market. His partnerships have been instrumental in the success of his projects.

Conclusion: John E Macor's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in Guilford, CT, and beyond. His contributions continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.